Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Porvair Expands Its Operations at New Milton

Published: Thursday, February 13, 2014
Last Updated: Thursday, February 13, 2014
Bookmark and Share
Expansion to provide manufacturing capacity to support future growth of the business.

Porvair Filtration Group has announced the expansion of its UK facilities in New Milton near Christchurch. The new factory purchased this month will allow a consolidation of Porvair’s business in the UK and provides much needed manufacturing capacity to support the future growth of the business.

Porvair Filtration Group, whose parent company, Porvair plc, saw revenues grow by 10% last year, will consolidate its activities in the market for industrial filtration and separation products on the new site. Tom Liddell, Managing Director of Porvair Filtration Group commented, ‘At over 40,000 square feet, the new facility will allow us to integrate a number of activities within smaller units in the area, gaining efficiency in our operations and giving us space to sustain our growth. The investment is significant, but it is consistent with the sizeable growth opportunity we see for our products in the industrial process market.’

Porvair Filtration Group has supplied the process industry for over 25 years, with innovative and performance driven filtration equipment (elements, cartridges and vessels). The process industry demands filters that can withstand the most extreme and aggressive conditions of temperature, pressure and corrosion, whilst safeguarding operators and systems from particulates and ensuring environmental protection. Each filtration and separation requirement presents its own critical challenges and requires superior reliability, durability and a robust product construction. Porvair Filtration Group provide highly specialised filtration solutions for use throughout the manufacturing process and have proven filtration solutions for the production of chemicals such as nitric acid, maleic anhydride, caprolactum, hydrogen peroxide, sulphuric acid, phosphoric acid, magnesium nitrate, as well as HDPE and LLDPE. By using the latest in metallic filter media technology, Porvair are able to provide improved performance, and reduced plant operating costs, enabling longer campaigns and greater materials recovery.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Contract Design, Manufacture and Assembly of Regulatory Compliant Polymer Products
Porvair Filtration Group has opened a new Class 100000 clean room facility at its Wrexham, UK site.
Friday, March 12, 2010
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos